Cargando…
Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management
Aspirin is one of the most widely used medications across the global healthcare system and is the foundation in treating ischemic heart disease, as well as secondary prevention for ischemic and valvular heart disease. Challenges arise in treating patients with cardiovascular disease who have concomi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135937/ https://www.ncbi.nlm.nih.gov/pubmed/35344187 http://dx.doi.org/10.1007/s40119-022-00255-9 |
_version_ | 1784714067997360128 |
---|---|
author | Thakker, Ravi A. Salazar, Leonardo Jazar, Deaa Abu Bhakta, Pooja Baker, Bryan Patel, Chandani Elbadawi, Ayman Agarwal, Mayank Albaeni, Aiham Saleh, Mohammed Esclovan, Jonathan El Haddad, Danielle Alwash, Hashim Kalra, Ankur Goel, Sachin S. Widmer, Robert Jay Chatila, Khaled Khalife, Wissam Motiwala, Afaq McCracken, Jennifer Jneid, Hani Gilani, Syed |
author_facet | Thakker, Ravi A. Salazar, Leonardo Jazar, Deaa Abu Bhakta, Pooja Baker, Bryan Patel, Chandani Elbadawi, Ayman Agarwal, Mayank Albaeni, Aiham Saleh, Mohammed Esclovan, Jonathan El Haddad, Danielle Alwash, Hashim Kalra, Ankur Goel, Sachin S. Widmer, Robert Jay Chatila, Khaled Khalife, Wissam Motiwala, Afaq McCracken, Jennifer Jneid, Hani Gilani, Syed |
author_sort | Thakker, Ravi A. |
collection | PubMed |
description | Aspirin is one of the most widely used medications across the global healthcare system and is the foundation in treating ischemic heart disease, as well as secondary prevention for ischemic and valvular heart disease. Challenges arise in treating patients with cardiovascular disease who have concomitant aspirin intolerance. Through an extensive review of the literature, we provide a comprehensive background on the pharmacology of aspirin, the mechanisms behind aspirin intolerance, the importance of aspirin in cardiovascular disease, and the management of aspirin intolerance in both acute coronary syndrome and stable coronary artery disease. Our review includes a multidisciplinary approach from the internist, allergist/immunologist, and cardiologist when evaluating this important patient population. |
format | Online Article Text |
id | pubmed-9135937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-91359372022-05-28 Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management Thakker, Ravi A. Salazar, Leonardo Jazar, Deaa Abu Bhakta, Pooja Baker, Bryan Patel, Chandani Elbadawi, Ayman Agarwal, Mayank Albaeni, Aiham Saleh, Mohammed Esclovan, Jonathan El Haddad, Danielle Alwash, Hashim Kalra, Ankur Goel, Sachin S. Widmer, Robert Jay Chatila, Khaled Khalife, Wissam Motiwala, Afaq McCracken, Jennifer Jneid, Hani Gilani, Syed Cardiol Ther Review Aspirin is one of the most widely used medications across the global healthcare system and is the foundation in treating ischemic heart disease, as well as secondary prevention for ischemic and valvular heart disease. Challenges arise in treating patients with cardiovascular disease who have concomitant aspirin intolerance. Through an extensive review of the literature, we provide a comprehensive background on the pharmacology of aspirin, the mechanisms behind aspirin intolerance, the importance of aspirin in cardiovascular disease, and the management of aspirin intolerance in both acute coronary syndrome and stable coronary artery disease. Our review includes a multidisciplinary approach from the internist, allergist/immunologist, and cardiologist when evaluating this important patient population. Springer Healthcare 2022-03-28 2022-06 /pmc/articles/PMC9135937/ /pubmed/35344187 http://dx.doi.org/10.1007/s40119-022-00255-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Review Thakker, Ravi A. Salazar, Leonardo Jazar, Deaa Abu Bhakta, Pooja Baker, Bryan Patel, Chandani Elbadawi, Ayman Agarwal, Mayank Albaeni, Aiham Saleh, Mohammed Esclovan, Jonathan El Haddad, Danielle Alwash, Hashim Kalra, Ankur Goel, Sachin S. Widmer, Robert Jay Chatila, Khaled Khalife, Wissam Motiwala, Afaq McCracken, Jennifer Jneid, Hani Gilani, Syed Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management |
title | Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management |
title_full | Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management |
title_fullStr | Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management |
title_full_unstemmed | Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management |
title_short | Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management |
title_sort | coronary artery disease and aspirin intolerance: background and insights on current management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135937/ https://www.ncbi.nlm.nih.gov/pubmed/35344187 http://dx.doi.org/10.1007/s40119-022-00255-9 |
work_keys_str_mv | AT thakkerravia coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT salazarleonardo coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT jazardeaaabu coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT bhaktapooja coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT bakerbryan coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT patelchandani coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT elbadawiayman coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT agarwalmayank coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT albaeniaiham coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT salehmohammed coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT esclovanjonathan coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT elhaddaddanielle coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT alwashhashim coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT kalraankur coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT goelsachins coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT widmerrobertjay coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT chatilakhaled coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT khalifewissam coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT motiwalaafaq coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT mccrackenjennifer coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT jneidhani coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement AT gilanisyed coronaryarterydiseaseandaspirinintolerancebackgroundandinsightsoncurrentmanagement |